» Articles » PMID: 28234952

Endomyocardial Involvement in Asymptomatic Sub-Saharan Immigrants with Helminth-related Eosinophilia

Abstract

Background: Among immigrants of sub-Saharan origin, parasitic infection is the leading cause of eosinophilia, which is generally interpreted as a defense mechanism. A side effect of the inflammatory mediators released by eosinophils is damage to host organs, especially the heart. The main objectives of this study were to i) assess cardiac involvement in asymptomatic sub-Saharan immigrants with eosinophilia, ii) relate the presence of lesions with the degree of eosinophilia, and iii) study the relationship between cardiac involvement and the type of causative parasite.

Methodology/principle Findings: In total, the study included 50 black immigrants (37 patients and 13 controls) from sub-Saharan Africa. In all subjects, heart structure and function were evaluated in a blinded manner using Sonos 5500 echocardiographic equipment. The findings were classified and described according to established criteria. The diagnostic criteria for helminthosis were those reported in the literature. Serum eosinophil-derived neurotoxin levels were measured using enzyme-linked immunosorbent assay. A significant association was found between the presence of eosinophilia and structural alterations (mitral valve thickening). However, the lack of an association between the degree of eosinophilia and heart valve disease and the absence of valve involvement in some patients with eosinophilia suggest the role of other factors in the appearance of endocardial lesions. There was also no association between the type of helminth and valve involvement.

Conclusions: We, therefore, suggest that transthoracic echocardiography be performed in every sub-Saharan individual with eosinophilia in order to rule out early heart valve lesions.

Citing Articles

Endomyocardial involvement in asymptomatic Latin American migrants with eosinophilia related to helminth infection: A pilot study.

Sempere A, Salvador F, Mila L, Casas G, Dura-Miralles X, Sulleiro E PLoS Negl Trop Dis. 2024; 18(8):e0012410.

PMID: 39102438 PMC: 11326544. DOI: 10.1371/journal.pntd.0012410.


Effects of helminths and anthelmintic treatment on cardiometabolic diseases and risk factors: A systematic review.

Pham K, Mertelsmann A, Mages K, Kingery J, Mazigo H, Jaka H PLoS Negl Trop Dis. 2023; 17(2):e0011022.

PMID: 36827239 PMC: 9956023. DOI: 10.1371/journal.pntd.0011022.


Eosinophils and helminth infection: protective or pathogenic?.

Mitre E, Klion A Semin Immunopathol. 2021; 43(3):363-381.

PMID: 34165616 DOI: 10.1007/s00281-021-00870-z.

References
1.
Bustinduy A, Luzinda K, Mpoya S, Gothard P, Stone N, Wright S . Endomyocardial fibrosis (EMF) in a Ugandan child with advanced hepatosplenic schistosomiasis: coincidence or connection?. Am J Trop Med Hyg. 2014; 91(4):798-800. PMC: 4183407. DOI: 10.4269/ajtmh.14-0156. View

2.
Mocumbi A, Ferreira M, Sidi D, Yacoub M . A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med. 2008; 359(1):43-9. DOI: 10.1056/NEJMoa0708629. View

3.
Morioka J, Kurosawa M, Inamura H, Nakagami R, Mizushima Y, Chihara J . Development of a novel enzyme-linked immunosorbent assay for blood and urinary eosinophil-derived neurotoxin: a preliminary study in patients with bronchial asthma. Int Arch Allergy Immunol. 2000; 122(1):49-57. DOI: 10.1159/000024358. View

4.
Yalonetsky S, Mishaly D, Ben-Barak A, Lorber A . Mitral valve destruction by Hodgkin's lymphoma-associated Loefler endocarditis. Pediatr Cardiol. 2007; 29(5):983-5. DOI: 10.1007/s00246-007-9135-6. View

5.
Grimaldi A, Mocumbi A, Freers J, Lachaud M, Mirabel M, Ferreira B . Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives. Circulation. 2016; 133(24):2503-15. DOI: 10.1161/CIRCULATIONAHA.115.021178. View